Nasdaq: IMVT
Immunovant insiders
The officers, directors and 10% owners of Immunovant, Inc. who hold the most stock, valued at the live IMVT price.
$32.52
IMVT today −$650K (−1.96%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 14
- Their IMVT stock
- $3.85B
- Market value
- $6.92B
- Held by ranked insiders
- 55.6%
Insiders by value of IMVT holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Roivant Sciences Ltd. | Director | 113,317,007 | $3.69B | 53.2% | Corporate |
| 2 | Peter Salzmann | Chief Executive Officer | 1,178,191 | $38.3M | 0.55% | 3096th |
| 3 | Frank Torti | Director | 1,009,228 | $32.8M | 0.47% | 475th |
| 4 | Julia G. Butchko | Chief Development Officer | 440,959 | $14.3M | 0.21% | 6678th |
| 5 | Eva Renee Barnett | Chief Financial Officer | 396,774 | $12.9M | 0.19% | 7247th |
| 6 | William L. Macias | Chief Medical Officer | 357,353 | $11.6M | 0.17% | 7852nd |
| 7 | Mark S. Levine | Chief Legal Officer | 319,228 | $10.4M | 0.15% | 8556th |
| 8 | Eric Venker | Chief Executive Officer | 257,075 | $8.4M | 0.12% | 3014th |
| 9 | Tiago Girao | Chief Financial Officer | 234,192 | $7.6M | 0.11% | 10730th |
| 10 | Michael Geffner | Chief Medical Officer | 217,958 | $7.1M | 0.10% | 11299th |
| 11 | Melanie Gloria | Chief Operating Officer | 217,060 | $7.1M | 0.10% | 11328th |
| 12 | Jay Stout | Chief Technology Officer | 198,937 | $6.5M | <0.1% | 12087th |
| 13 | Christopher Van Tuyl | Chief Legal Officer | 175,218 | $5.7M | <0.1% | 13222nd |
| 14 | Jake Bauer | Director | 38,896 | $1.3M | <0.1% | 13846th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Immunovant; see each profile for the filing.